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RUNNING TITLE: 
Hippocampal sub-structures at 7T. 
 
 
  
ABSTRACT 
 
Purpose: To provide a more detailed investigation of hippocampal subfields using ultra-
high field magnetic resonance imaging (MRI) for the identification of hippocampal 
pathologies in temporal lobe epilepsy. 
Materials and Methods: Patients (N=13) with drug-resistant TLE (9 with HS-no, 4 HS) 
and 20 age-matched healthy controls were scanned and compared using a 7T MRI 
protocol. Using a manual segmentation scheme to delineate hippocampal subfields, 
subfield-specific volume changes and apparent transverse relaxation rate (𝑅2
∗) were 
studied between the two groups. In addition, radiological patient assessment at 7T and 
clinical outcomes were correlated with measured subfield changes.   
Results: Volumetry of the hippocampus at 7T in HS patients revealed significant 
ipsilateral subfield atrophy in CA1 and CA4DG. Volumetry also uncovered subfield 
atrophy in 33% of HS-no patients, which had not been detected using conventional 
imaging.  
Conclusions: These preliminary findings indicate that hippocampal subfield volumetry 
assessed at 7T may be superior to conventional (1.5T) visual inspection by a 
neuroradiologist in the identification of hippocampal pathologies in TLE, however 
difficulty remains in identifying HS-no cases by imaging.  
 
KEY WORDS 
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INTRODUCTION 
Temporal lobe epilepsy (TLE) is the most common form of adult focal epilepsy. For 
approximately 30% of TLE patients the condition is medically intractable (1), with 
surgical treatment as the standard of care. Surgical resection of the affected region of the 
brain aims to remove the seizure-inducing epileptogenic foci while excluding eloquent 
cortex and pathways, crucial for sensory, motor, and linguistic function. However, less 
than 50% of patients become seizure-free at 10 years after surgery (2), and there is a risk 
of deficit in language, auditory, and cognitive processes from damage to surrounding 
cortex and pathways (3). 
 
The pathology of TLE most commonly manifests as hippocampal sclerosis (HS), 
characterized by neuronal loss and gliosis of specific subfields of the hippocampus and 
clinically by increased signal intensity on imaging (4, 5). Although lesions associated 
with the epileptogenic focus, like HS, can often be identified by MRI, many of the HS-no 
patients have unidentifiable lesions on conventional 1.5T MRI (6). In cases with 
identifiable HS, post-operative surgical outcomes are more favourable when compared to 
MRI-negative cases (4, 7–9). Furthermore, histopathological studies looking at subfield 
atrophy patterns in TLE patients with HS demonstrate that patients with more extensive 
subfield atrophy are more likely to become seizure free than those with more limited 
neuron loss (4, 8). Hence, having pre-operative knowledge pertaining to the extent and 
distribution of hippocampal neuronal loss may give insight into the prognosis of surgical 
candidates, potentially affecting surgical planning. 
 
The hippocampus is a compound temporal lobe structure of the brain traditionally divided 
into the hippocampal head, body, and tail. The hippocampal body comprises structurally 
and functionally distinct subregions (subfields) (10); the subiculum (SUB), ammon’s 
horn (CA1-CA4), and dentate gyrus (DG). Histopathological studies have shown that 
disease processes selectively affect the different morphologically and functionally 
distinct subfields of the hippocampus (11, 12), for instance TLE has been characterized 
by loss of tissue in the CA1, DG, and global hippocampal atrophy (13–16). To study this 
further, Mueller et al. (2009) manually segmented the hippocampi of TLE patients to 
demonstrate the validity of using subfield volumetry in the detection of hippocampal 
atrophy at 4T MRI. In their study, regional hippocampal volume losses in CA1, CA3, and 
DG, with relative sparing of CA2 was detected in TLE patients with HS defined by visual 
assessment at 1.5T. Furthermore, the authors suggest the superiority of subfield 
volumetry over conventional hippocampal volumetry for the detection of hippocampal 
pathologies in TLE. This claim was moderately supported through the detection of 
hippocampal volume losses in 17% of TLE patients without identified HS (Mueller et al., 
2009). 
 
Clinical 1.5T and 3.0T MRI scanners have limited ability to image the internal 
architecture of the hippocampus due to spatial resolution, contrast, and imaging 
constraints (18). Higher field strength MRI scanners provide a gain in intrinsic MR signal 
because of the linear relationship between the signal to noise ratio (SNR) and magnetic 
field strength. This increased SNR can also be exploited through imaging with increased 
resolution at 7T, which can consistently reveal hippocampal subfield morphometry at 
300-500µm within a clinically acceptable imaging duration (19, 20). This advancement in 
imaging technology gives us the capability to study minute changes in hippocampal 
anatomy associated with TLE ideally suitable for clinical, in-vivo, and preoperative 
analysis. 
 
Susceptibility weighted imaging (SWI) is an MRI technique that takes advantage of 
magnetic susceptibility differences between different tissues, for example blood, iron, 
and calcifications. One measure of SWI is the apparent transverse relaxation rate (𝑅2
∗). 
Previous work investigated the use of susceptibility related contrast for in vivo 
characterization of the hippocampal subfields at 7T and found significant differences in 
𝑅2
∗ across adjacent subfields (21). Therefore, this work suggests that quantitative maps 
based on SWI may be superior in sensitivity for the detection of abnormalities of specific 
hippocampal subfields than magnitude images and provides motivation for analysis of 
subfield composition in healthy and diseased populations (21). 
 
The study of hippocampal subfield volumetry may be superior compared to conventional 
hippocampal volumetry for the detection of hippocampal pathologies in TLE. 
Furthermore, the identification of HS is clinically important in predicting surgical 
outcomes. In cases where gross HS is not identifiable in clinical 1.5T MRI, a more 
detailed analysis of hippocampal subfields using high field MRI may reveal areas of 
sclerosis. The effectiveness of ultra-high field magnetic resonance techniques in 
assessing and localizing abnormal structure of the temporal lobe was studied here. This 
work focused mainly on in-vivo detection of pathological TLE sub-types as the principle 
objective. This goal was accomplished through the development of a normative database 
of hippocampus structure using healthy volunteer 7T MRI scans. Using a manual 
segmentation scheme to delineate hippocampal subfields, this normative database was 
used to compare hippocampal subfield volume and 𝑅2
∗ between healthy controls and TLE 
patients. Subfield-specific changes in volume and 𝑅2
∗ were studied and radiological 
patient assessment at 7T was correlated with measured subfield changes and surgical 
outcomes. 
 
MATERIALS AND METHODS 
 
Study Population 
 
Thirteen patients with drug-resistant TLE were recruited from the London Health 
Sciences Centre Comprehensive Epilepsy program, where they underwent continuous 
video-EEG monitoring followed by anterior temporal lobectomy. All recruited patients 
had preoperative investigations including neuropsychological testing and a 1.5T MRI 
with epilepsy protocol. Clinical data were collected for each patient, including age at 
surgery, gender, suspected epilepsy type, clinical 1.5T MRI reports, EEG reports, 
subdural electrode recording reports, clinical follow-up notes post resection and 
corresponding histopathology reports if applicable. This project was approved by the 
Office of Research and Ethics of Western University, and informed consent was obtained 
from all patients prior to their recruitment in the study. Exclusion criteria included 
patients with severe coexisting medical conditions and those unsuitable for MRI 
evaluation. Nine patients (mean age 31 ± 12.57, left TLE/right TLE 6/3, female/male 3/6) 
had normal-appearing hippocampi on their 1.5T MR examinations (HS-no) and 4 patients 
(mean age 36 ± 12.78, left TLE/right TLE 2/2, female/male 3/1) had evidence of HS on 
their 1.5T MR images in visual assessment by an experienced neuroradiologist (Table 1). 
The control population consisted of 20 healthy volunteers (mean age 31.2, female/male 
10/10). 
 
MRI Acquisition 
 
Ultra-high field data were acquired on a 7 T neuroimaging optimized MRI scanner 
(Agilent, Santa Clara, CA, USA/ Siemens, Erlangen, Germany) using a 16-channel 
transmit- receive head coil array constructed in-house. The imaging sequences used for 
this study were multi-echo gradient-echo sequences with six echoes acquired and a 0.5 
mm in-plane resolution (TR=40 ms, TE1=4.57 ms, echo spacing=4.89 ms, flip 
angle=13, N=1, matrix=256 x 360,  80 slices, slice thickness=1.5 mm, FOV=128 
x 180 x 120 mm, total time=12 min). Slices were acquired perpendicular to the long axis 
of the hippocampus in a coronal oblique orientation, in addition to a T1-weighted 
MPRAGE sequence (matrix=256x512x172, resolution=0.58x0.43x1 mm, scan time = 
5:42 min). These images were assigned randomized IDs assigned for visual interpretation 
by the neuroradiologists. We bias-corrected the images by employing the non-uniformity 
correction filter (N4) (22). 
 
Radiological Assessment 
 High-resolution images acquired at 7 Tesla had mesial temporal internal architecture and 
mesial temporal size graded on a 4-point scale (normal, probably normal, possibly 
abnormal, and definitely abnormal) by an experienced neuroradiologist while blinded to 
clinical data. This data was used and further analyzed in our previous paper currently in 
submission (Kwan B, manuscript submitted). For the purpose of this study, if either 
mesial temporal internal architecture or mesial temporal size was abnormal it was 
designated hippocampal abnormality (HL). If both size and architecture were abnormal it 
was designated hippocampal sclerosis (HS). The criteria used for classification includes 
size differences (atrophy), abnormality in shape, and increased signal. 
 
Manual Marking of Hippocampal Subfields 
 
An ultra-high field 7T MRI protocol for manual hippocampal subfield delineation was 
adapted from the 4T subfield delineation protocol proposed by (23) as well as the 
Duvernoy et al. (2005) atlas (10). This method for manual hippocampal subfield 
delineation was described in detail by Goubran et al., (2014) (Figure 1). Subfields were 
segmented in the body of the hippocampus only, defined as 6 slices just posterior to the 
head of the hippocampus. The following subregions were segmented in these 6 slices; 
Subiculum (Sub), Ammon’s horn (CA1-CA3), and CA4+Dentate Gyrus (DG). The SUB 
is defined as the most medial border of the temporal cortex and its border with CA1 as a 
vertical line at the edge of the SUB touching the most medial border of the DG+CA4 
region. The CA1/CA2 boundary is defined as the point where a noticeable decrease in 
width of the CA1 subfield is observed. The overall shape of the hippocampal formation 
through the body slices was determined by the course of the outer boundary of the 
hippocampus and the hypointense line representing myelinated tissue in the strata 
moleculare/lacunosum (SLM). The opening of subfields into the globular region of the 
hippocampal formation defines the CA3/DG+CA4 border, which was specifically 
identified by the continuation of a clear consistent hypointense line representing the SLM 
of CA and dendrites of the molecular layer of DG, as described by (24). 
 
With the manual segmentation protocol defined, it was implemented on 33 randomized 
subjects using the ITKsnap software (25). All images were visually inspected for 
accuracy and edited when necessary. 
 
Quantitative Measurements 
 
Using the FSL software the mean volume of each subfield was computed and used for 
subsequent analysis (26). 
 
The apparent transverse relaxation rate, 𝑅2
∗ =
1
𝑇2
∗ , was calculated using a Levenberg–
Marquardt, least-squares fitting routine for non-linear equations. Specifically, the 
following mono- exponential decay function: 
𝑆(𝑇𝐸) = 𝑆0 ∙ exp(−𝑇𝐸 ∙ 𝑅2
∗)                                                       (1) 
was fit to the magnitude data on a voxel-by voxel basis. In Eq. (1), TE represents the 
echo time in ms and 𝑆0 the signal intensity at 𝑇𝐸 = 50. The mean 𝑅2
∗ over each subfield 
area was computed and used for subsequent analysis. 
 
Statistical Analysis 
 
For members of the control group, the right and left hippocampi were treated separately 
for the purpose of analysis. The subfield and whole hippocampal volume and 𝑅2
∗ data for 
each of the control hippocampi were averaged for comparison with the patient 
population. Patient volume and 𝑅2
∗ data were separated into ipsi- and contralateral 
designations. Multivariate analyses of covariance (MANCOVAs) were performed with 
ipsilateral subfield or whole hippocampal volumes as dependent variables. This analysis 
addressed the question of whether subfield volume depends on the group designation 
(HS, HS-no, control), when you control for age and intracranial volume (ICV). A Tukey 
post hoc analyses was completed for the MANCOVAs. This was similarly repeated for 
ipsilateral 𝑅2
∗ and their contralateral counterparts. 
 
Normalized z-scores were computed using the control data to compare the severity of 
volume and 𝑅2
∗ deviations between different subfields. The volumes were first 
normalized for head size and converted into z-scores in the same manner outlined by 
Mueller et al., (2009). Analyses of variance (ANOVAs) and Tukey post hoc analyses 
were used to assess subfield atrophy. These z-scores were further used to identify subject-
specific patterns of change in volume or 𝑅2
∗. Additionally, the Pearson Correlation was 
used to compare the radiological assessment of mesial temporal internal architecture and 
mesial temporal size with the quantitative measures of subfield volume. 
 
For patients that underwent surgical resection, outcomes were assessed using Engel 
classification (27). Its correlation with subfield volume and 𝑅2
∗ and radiological 
assessment was determined using the Pearson Correlation. 
 
RESULTS 
 
7 Tesla Volumetry 
 
A significant ipsilateral volume group effect was revealed by MANCOVA [group: 
Wilks’ Lambda 0.620; F (10,88) = 2.375; p = 0.015], indicating that there were 
differences between the HS, HS-no, and control groups for the CA1 (p = 0.009), 
CA2+CA3 (p = 0.005), and CA4+DG (p < 0.001) ipsilateral subfields and whole 
hippocampal volume (p = 0.001). Conversely, no significant contralateral volume group 
effects were revealed by MANCOVA, meaning contralateral subfields or whole 
hippocampal volumes were not different between the three groups. The Tukey post hoc 
analyses on the ipsilateral volume showed that the HS group had significantly smaller 
CA1 and CA4+DG subfields and a smaller whole hippocampus than controls (p = 0.001, 
p < 0.001, p < 0.001) and HS-no patients (p = 0.013, p < 0.001, p = 0.001). There was a 
trend towards an ipsilateral volume loss in CA2+CA3. Additionally, the ipsilateral 
subfield and whole hippocampal volumes in the HS-no group were not different from 
those in controls (Table 2).  
 
Likewise for 𝑅2
∗, a significant ipsilateral group effect was revealed by MANCOVA 
[group: Wilks’ Lambda 0.603; F (10,88) = 2.531; p = 0.010] for the CA4+DG subfield (p 
= 0.001) and and the whole hippocampal 𝑅2
∗ (p = 0.008) and none revealed 
contralaterally. Tukey post hoc analyses of the ipsilateral HS 𝑅2
∗ showed significantly 
lower 𝑅2
∗ in the CA4+DG subfield (p = 0.001) and the whole hippocampus (p = 0.029) 
compared to controls but not significantly lower than the HS-no group. Ipsilateral 
subfield and whole hippocampus 𝑅2
∗ in the HS-no group were not different from those in 
controls (Table 2).  
 
After subfield-specific volume losses were found, an ANOVA was performed using the 
normalized subfield volume z-scores to identify the subfields that are most affected in 
TLE-HS (Figure 2). Firstly, the ANOVA revealed a significant ipsilateral subfield effect 
[F(4,15) = 6.07; p = 0.004] for HS patients. This effect was limited to only the ipsilateral 
side and not the contralateral or HS-no patients. An ANOVA was similarily performed 
using the subfield 𝑅2
∗ z-scores and revealed no ipsilateral or contralateral subfield effects 
in either HS or HS-no patients. Post-hoc analyses on the normalized subfield volume z-
scores of HS patients revealed significantly smaller CA1 and CA4+DG z-scores 
compared to the Sub subfield. The whole hippocampus z-score on the sclerotic side was 
also significantly smaller than the z-score for the Sub subfield. The HS-no group showed 
no significant effect for ipsi- or contralateral subfield z-scores. This indicates a selective 
volume loss in these subfields (Figures 2, 3, and 4). 
 
The normalized z-scores were used to quantify the subject-specific change in volume and 
𝑅2
∗ relative to the healthy control group (Table 3). This uncovered volume loss in 3 of 9 
HS-no patients. One patient (#8) demonstrated evidence for severe subfield atrophy (z-
score ≤ -2) in a pattern resembling that uncovered for HS patients. This patient showed 
severe ipsilateral volume loss in the CA4+DG subfield and less severe losses (z-score ≤ -
1) in CA1 and CA2+CA3 (Figure 3 and 4). The ipsi- and contralateral whole 
hippocampal volume of this patient was also greater than one standard deviation from the 
mean of the HS-no group. The two other HS-no patients (patients #9 and #11) showed 
evidence for considerable contralateral CA2+CA3 subfield atrophy (z-score ≤ -1). These 
patients had ipsi- and contralateral whole hippocampal volumes within the normal range 
of all HS-no patients.  
 
Radiological Assessment 
 
The 7T images were assessed by an experienced radiologist looking specifically at mesial 
temporal internal architecture and mesial temporal size. This assessment was presented in 
depth in our previous paper currently in submission (Kwan B, manuscript submitted). 
Briefly, 7T MRI revealed structural lesions in 6 of 9 HS-no patients (Table 4).  
 
Quantitatively, Pearson Correlation was used to determine the relationship between the 
qualitative assessment at 7T and hippocampal subfield volumetry. The radiological 
assessment of mesial temporal size demonstrated greatest correlation with the normalized 
volume z-scores of the CA1 and CA4+DG subfields and the whole hippocampal label, 
the correlations were -0.33, -0.39, and -0.28 respectively. Similarly, the radiological 
assessment of mesial temporal internal architecture had greatest correlation with the same 
subfields and coefficients of -0.22, -0.25, -0.30. Although there appeared to be a trend, no 
significance was achieved for any of the correlations with P >0.05. 
 
Surgical Outcomes 
 
Patients undergoing temporal lobe resection were monitored through follow-up to assess 
their seizure control following surgery. Engel classification was assigned to each patient 
following resection and a Pearson correlation was calculated to determine the relationship 
between hippocampal volume at 7T and surgical outcomes. There was no significant 
correlation found between Engel classification and ipsilateral whole hippocampal and 
subfield volume and 𝑅2
∗ (p > 0.05) using a Pearson correlation. Furthermore, there was no 
significant correlation (p > 0.05) between surgical outcomes and the radiographic 
assessment of hippocampal abnormality. 
 
DISCUSSION 
 
The higher spatial resolution provided by ultra-high-field magnetic resonance imaging 
(MRI) at 7 Tesla, allowed improved signal-to-noise ratio revealing internal sub-structures 
of the hippocampus, not visible at the resolution provided by 1.5 Tesla. This work aimed 
to use the increased resolution for in-vivo detection of pathological TLE sub-types for the 
better prediction of surgical outcomes. To this end, a normative database of hippocampal 
sub-structures was developed through the manual segmentation of healthy volunteer MRI 
scans at 7 Tesla. Using the normative database, pre-operative and patient-specific 
analyses were made, comparing volumetric and apparent transverse relaxation rate (𝑅2
∗) 
between patients with TLE and the normative database. These comparisons were made to 
assess and localize structural abnormalities in the hippocampal sub-structures of TLE 
patients. Characteristic atrophy patterns were found in HS patients in the ipsilateral CA1 
and CA4+DG subfields, as well as ipsilateral whole hippocampal atrophy. Three of the 
HS-no patients demonstrated subfield atrophy (z-score <-1) using 7T volumetry. 
Furthermore, 67% of HS-no patients showed radiologist identifiable abnormality at 7T, 
indicating improved identification of abnormality at higher field strength. The novel pre-
operative imaging techniques utilized in this project may help predict long-term surgical 
outcomes by identifying sclerotic and non-sclerotic sub-types of TLE prior to surgery. 
However, in this study the surgical outcomes were followed and no significant 
correlation was found. 
 
Increased resolution and improved signal-to-noise at 7 Tesla allowed the marking of 
hippocampal subfields in healthy controls and TLE patients with and without HS. 
Attempts at a universal hippocampal segmentation protocol have been made (28, 29), 
however still debated. At the time of this study there existed no agreed upon 
segmentation protocol and thus a manual segmentation protocol was employed. The 
manual marking scheme used was based on details of internal structure of the 
hippocampus visible on high resolution T2-weighted images at 7T. Features were chosen 
that were reliably identifiable even in cases of severe sclerosis. As Mueller et. al. (2009) 
uncovered, there is preservation of internal architecture at higher field strengths, 
particularly 4T. A similar preservation of architecture was found at 7T in HS patents, 
despite one of the main radiographic criteria for HS in clinical 1.5T MRI is signal 
abnormality and loss of the internal architecture. Although the appeal of using 7T MRI is 
the higher resolution it offers, it is still not sufficient to reliably and accurately identify 
the boundaries of each of the hippocampal subfield. Therefore, similar to Mueller et. at. 
(2009), reliable hippocampal landmarks in addition to radiographic landmarks were used 
to designate the hippocampal subfields.  
 
Volumetry of the hippocampus at 7T in HS patients revealed a characteristic pattern of 
significant global ipsilateral hippocampal atrophy, restricted subfield losses in CA1 and 
CA4+DG, and no significant contralateral volume losses. These results confirm those that 
have been found at 3T (30) and 4T (17), histological studies (31), as well as combined 
MRI-histology investigations (5) for patients with medically intractable TLE. The same 
marking scheme was used to assess the 𝑅2
∗ signal within the hippocampal subfields of 
HS, HS-no, and control groups. Although some significant subfield reductions in 𝑅2
∗ were 
measured between HS and the HS-no group, it was not possible to draw conclusions 
about the 𝑅2
∗ signal changes in TLE at 7T from this data without significant differences 
form the control group. 
 
Not only did volumetry reveal the expected pattern of atrophy in this study but it was 
observed for each subject clinically identified as having HS, therefore confirming the 
clinical designation of HS. However, of note is the ability of 7T volumetry to go beyond 
the clinical designation of sclerosis and identify additional cases of sclerosis in 33% of 
HS-no patients in this study. Similar to the HS patients, who were characterized in this 
study by CA1, CA4+DG, and trending CA2+CA3 subfield atrophy, one of the HS-no 
patients (patient #8) demonstrated a near identical pattern of atrophy. This may represent 
a patient with less severe HS, whose diagnosis of HS was missed on 1.5T clinical MRI. 
Therefore, the resolution provided by 7T MRI may provide novel information about TLE 
pathology not available by conventional imaging. The other two HS-no patients 
displaying subfield atrophy (patients #9 and #11), had volume losses mainly limited to 
the contralateral CA2+CA3 subfield. This difference in atrophy pattern between HS 
patients and HS-no patients suggests that patients with MRI-negative epilepsy isn’t just a 
less advanced form of HS TLE but is instead a different type of TLE and is a testament to 
the heterogeneity of cases of MRI-negative epilepsy (6). 
 
For this study, patients were initially classified as having HS or HS-no TLE clinically at 
1.5T. Subsequently, following preoperative imaging at 7T, an experienced radiologist 
judged the scans on the basis of mesial temporal internal architecture and mesial temporal 
size. Blinded to the patient’s initial classification, at 7T the radiologist confirmed 
abnormal internal architecture and size corresponding to clinically classified HS patients. 
Patients determined to have abnormal architecture or size at 7T also had lower 
quantitative volumes in a pattern similar to that revealed by volumetry, selective losses in 
CA1, CA4+DG, and the whole hippocampus label. However, the correlation was not 
significant. Although the superiority 7T volumetry compared to conventional 1.5T visual 
assessment hasn’t been confirmed in this study, our previous work (Kwan B, manuscript 
submitted) holds promise in demonstrating that radiological assessment at 7T may be 
superior to conventional visual inspection by a neuroradiologist in the identification of 
hippocampal pathologies in TLE. Interestingly, the visual inspection at 7T detected 
abnormality in more cases of HS-no than volumetry. Visual inspection looked at features 
of size difference (atrophy), abnormality in shape, and increased signal, where as 
volumetry measured differences in subfield volume and 𝑅2
∗. Therefore, subfield-specific 
changes in shape or intensity may provide a fruitful area for further study. 
 
This study is limited by the inclusion of only thirteen TLE patients and thus the results 
must only be taken as preliminary. Secondly, although there are gains in intrinsic MR 
signal provided by higher field strength MRI scanners which result in improvements in 
spatial resolution, the boundaries between many subfields can only be defined 
microscopically, and thus the definitions here instead rely on geometric rules. Validation 
of the subfield marking scheme using neuronal cell counts on the resected tissue is 
considered future directions for improving the impact of this work. Currently only ten of 
thirteen patients have undergone surgery and resection. Of this subset, HS status has been 
confirmed but subfield-specific cell counts and correlation analysis still remains to be 
performed. A final limitation worth mentioning, similar to that which affected Mueller et. 
al. (2009), is that the hippocampal subfields were only marked in a small region of the 
anterior body, thus potentially missing atrophic changes restricted to the posterior 
body/tail and head of the hippocampus. Furthermore, there may be benefit in posterior 
atrophic changes and comparing these changes to those seen in the anterior body as a 
method of prognostication prior to surgery. It has been shown through histopathological 
studies that in TLE patients with atrophy restricted to the anterior hippocampus are more 
likely to benefit from surgery than those with diffuse atrophy (13). 
 
In conclusion in these preliminary findings, 7T volumetry demonstrated hippocampal 
atrophy patterns in excellent agreement with the typical patterns of atrophy identified in 
histological studies and studies at lower field strengths. Subfield volumetry also 
uncovered hippocampal subfield volume losses in 33% of HS-no patients, which had not 
been identified conventionally. This study suggests that hippocampal subfield volumetry 
or routine clinical radiological assessment by visual inspection at 7T may be superior to 
conventional visual inspection by a neuroradiologist in the identification of hippocampal 
pathologies in TLE, however there remains difficulty in identifying HS-no cases by 
imaging. 
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TABLES 
Table 1. Patient Characteristics. 
Patient Number Age at 
surgery
Gender Hemisphere of 
Seizure Onset
Age of seizure 
onset
1.5T MR Findings 1.5T MR 
Designation
Hippocampal pathology Follow up duration 
(Months)
Postsurgical 
outcome
1 20 M L 3 L HS, L occipital 
lobe 
encephalomalacia 
(remote)
L HS Gliosis (temporal 
neocortex and 
amygdala), mesial 
temporal sclerosis 
(hippocampus)
35 I
2 32 F L 19 L HS L HS Gliosis (temporal 
neocortex), mesial 
temporal sclerosis
27 I
3 49 F R 22 R HS, L 
periventricular 
heterotopia
R HS Gliosis (temporal 
neocortex), mesial 
temporal sclerosis
23 II
4 45 F R 3 R HS R HS
Gliosis (temporal lobe), 
mesial temporal sclerosis
39 I
5 18 M R 14 Possible R HS HS-no Gliosis (temporal 
neocortex, hippocampus 
and amygdala)
36 I
6 24 M L Normal HS-no Normal 7 I
7 NA M L 26 Temporal 
pole/gyrus rectus is 
slightly smaller on 
the left
HS-no No resection
NA NA
8 50 F L 47 Equivocal changes 
inferomedially in 
the left temporal 
pole
HS-no Gliosis (temporal 
neocortex, amygdala, 
and hippocampus)
36 IV
9 42 F R 8 Slightly increased 
T2 signal in the 
right hippocampus
HS-no Gliosis (temporal 
neocortex, amygdala, 
and hippocampus)
17 I
10 NA M L 18 Bifrontal 
periventricular 
heterotopia
HS-no No resection
NA NA
11 31 M R 28 Normal HS-no Mild cortical dysplasia, 
mild gliosis (temporal 
neocortex) 
18 I
12 23 M L 18 Normal HS-no Gliosis (temporal 
neocortex, amygdala, 
and hippocampus), focal 
cortical dysplasia type Ia 
(temporal neocortex)
18 I
13 NA F L 44 Normal HS-no No resection NA NA
R, right; L, left; HS, hippocampal sclerosis; MR, magnetic resonance; NA, not 
applicable. Post-surgical outcome classification; according to Engel’s classification of 
postoperative outcomes. 
Table 2: Mean and (SD) of subfield and total hippocampal volumes and 𝑅2
∗.
 
Units of subfield volume are in mm3. SD, standard deviation; HS, hippocampal sclerosis. 
† p < 0.05 compared to controls only. 
‡ p < 0.05 compared to both HS-no and control groups. 
 
Table 3:  Normalized ipsilateral z-scores for volume. 
Sub CA1 CA2+CA3 CA4+DG WholeHipp
1 L HS -0.44 -1.82 -0.76 -2.10 -1.58
2 L HS 0.02 -2.18 -0.70 -1.29 -2.08
3 R HS 0.46 -0.02 -0.96 -1.05 -1.31
4 R HS -0.11 -1.73 -1.12 -1.55 -1.39
5 HS-no 0.27 0.85 2.02 0.54 1.00
6 HS-no -1.12 0.40 0.68 0.93 -0.13
7 HS-no 0.02 -0.32 1.04 0.95 -0.05
8 HS-no -0.55 -1.22 -1.60 -2.01 -0.65
9 HS-no 1.10 -0.06 -0.88 0.58 0.39
10 HS-no -0.14 -0.95 0.15 0.05 0.66
11 HS-no 0.45 0.40 -0.14 0.66 0.84
12 HS-no -0.58 -0.09 0.63 1.33 -0.56
13 HS-no 2.14 1.41 -0.20 0.88 1.40
Patient	
Number
1.5T MR 
Designation
Hippocampal	Subfield
 HS, hippocampal sclerosis; MR, magnetic resonance. 
Table 4: Radiological assessment at 7T. 
Mesial Temporal 
Internal Architecture
Mesial Temporal Size
1 L HS L HS L definitely abnormal L definitely abnormal
2 L HS L HS L definitely abnormal L definitely abnormal
3 R HS R HS, L HL R possibly abnormal normal
4 R HS R HS R possibly abnormal R possibly abnormal
5 HS-no L HS L possibly abnormal L possibly abnormal
6 HS-no HS-no R probably normal normal
7 HS-no R HS R possibly abnormal R possibly abnormal
8 HS-no L HL normal L possibly abnormal
9 HS-no HS-no normal normal
10 HS-no R HL R possibly abnormal normal
11 HS-no L HS L possibly abnormal L possibly abnormal
12 HS-no HS-no R + L probably 
normal
R + L probably 
normal
13 HS-no R HL, L HL R possibly abnormal L possibly abnormal
7 Tesla MRI (radiological assesment)Patient 
Number
1.5T MR 
Designation
7T MR 
Designation
 
R, right; L, left; MR, magnetic resonance; HS, hippocampal sclerosis; HL, hippocampal 
abnormality (if either mesial temporal internal architecture or mesial temporal size is 
abnormal). 
  
FIGURE LEGENDS 
Figure 1: Segmentation scheme for manual marking of subfields. The scheme used was 
based on details of internal structure of the hippocampus visible on high resolution T2-
weighted images at 7T. A typical example of hippocampal subfield marking on in vivo 
T2-weighted 7T coronal images of a control subject. CA2-3, CA2-CA3 transition zone; 
CA4&DG, CA4 and dentate gyrus; Sub, subiculum.  Numbers 1-6 represents each 0.5mm 
slice of the hippocampal body that was segmented. No. 1 represents the most anterior 
slice and No. 6 the most posterior slice. 
Figure 2: Mean and standard deviation of (A) volume and (B) 𝑅2
∗ subfield z-scores for 
HS (blue) and HS-no (red) patients. *Indicates p < 0.05 compared to Sub. Sub, 
subiculum; WholeHipp, whole hippocampus label.  
Figure 3: Line plots demonstrating subject-specific patterns of ipsilateral atrophy. Z-
scores were calculated and plotted with respect to each subfield for every patient and 
grouped by 1.5T MRI designation. The single HS-no patient (patient # 8) demonstrating 
an atrophy pattern similar to those designated HS was grouped separately. Sub, 
subiculum; WholeHipp, whole hippocampus label. 
Figure 4: High resolution in vivo 7T T2-weighted representative coronal images of the 
hippocampal body demonstrating patterns of sclerotic change, with arrows indicating 
atrophy: (A) 33-year-old control. (B) 20-year-old HS patient with CA1 and CA4+DG 
volume loss and relative sparing of the other subfields. (C) 32-year-old HS patient with 
severe CA1 thinning and lesser CA4+DG atrophy with relative sparing of the other 
subfields. (D) 50-year-old HS-no patient with CA1 and CA4+DG volume loss (patient 
#8).  
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based on details of internal structure of the hippocampus visible on high resolution T2-
weighted images at 7T. A typical example of hippocampal subfield marking on in vivo 
T2-weighted 7T coronal images of a control subject. CA2-3, CA2-CA3 transition zone; 
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Figure 3: Line plots demonstrating subject-specific patterns of ipsilateral atrophy. Z-
scores were calculated and plotted with respect to each subfield for every patient and 
grouped by 1.5T MRI designation. The single HS-no patient (patient # 8) demonstrating 
an atrophy pattern similar to those designated HS was grouped separately. Sub, 
subiculum; WholeHipp, whole hippocampus label. 
 Figure 4: High resolution in vivo 7T T2-weighted representative coronal images of the 
hippocampal body demonstrating patterns of sclerotic change, with arrows indicating 
atrophy: (A) 33-year-old control. (B) 20-year-old HS patient with CA1 and CA4+DG 
volume loss and relative sparing of the other subfields. (C) 32-year-old HS patient with 
severe CA1 thinning and lesser CA4+DG atrophy with relative sparing of the other 
subfields. (D) 50-year-old HS-no patient with CA1 and CA4+DG volume loss (patient 
#8). 
